Basal Ganglia: Functions and Dysfunctions in Motor Control and Disease

Functional Organization and General Principles of the Basal Ganglia

The basal ganglia, historically referred to by Wilson in 1925 as ‘the dark basement of the brain,’ are essential structures for the automatic execution of learned motor plans, as described by C.D. Marsden in his 1982 Robert Wartenberg Lecture. These structures play a critical role in motor learning and reinforcement processes, involving both positive reinforcement and negative reinforcement, such as avoidance and punishment. To achieve precise movement control, the brain utilizes a complex circuit where the motor cortex is responsible for planification, initiation (via the M2 area), and execution (via the M1 area). The basal ganglia specifically handle voluntary movement, the selection of action, and the formation of skills. This system is supported by the cerebellum, which provides sensory integration and motor predictions; the motor thalamus, which serves as a relay for subcortical information; and the brainstem (specifically the Cuneiform Nucleus [CuN] and Pedunculopontine Nucleus [PPN]) for controlling locomotion parameters like initiation, termination, speed, and direction.

Anatomically, the basal ganglia are divided into input, output, and intermediate structures. The entry structures, which receive excitatory glutamatergic afferents from the cortex, are the striatum (composed of the noyau caud , putamen, and accumbens) and the subthalamic nucleus (NST). The striatum is overwhelmingly composed of medium spiny neurons ($95\%$). The exit structures project toward the thalamus and the brainstem; these include the globus pallidus internus (GPi), also known as the ventral pallidum, and the substantia nigra pars reticulata (SNr). Intermediate structures include the substantia nigra pars compacta (SNc), which is dopaminergic, and the globus pallidus externus (GPe). The system is organized somatotopically and influences the activity of frontal lobe neurons through GABAergic (inhibitory) pathways. A frontal section of the brain reveals the spatial relationship between these structures: the corpus callosum, thalamus, third ventricle, subthalamic nucleus, substantia nigra, caudate nucleus, putamen, internal capsule, pallidum, and red nucleus (noyau rouge).

Dynamic Models of Basal Ganglia Circuitry

Organization of the basal ganglia relies on two primary principles: the existence of opposing pathways and neurochemical compartments. The pathways include the ‘direct’ and ‘indirect’ loops that facilitate or inhibit movement. The striatum is further organized into the matrix, which receives sensorimotor cortical afferents, and striosomes, which receive limb cortical afferents (orbitofrontal, cingulate, and insular). Recent research by I. Lazaridis et al. (2024) indicates a non-canonical direct pathway expressing D1R that connects to the SNpc to inhibit dopamine release, and an indirect pathway expressing D2R that connects to the central GPe, which then projects to the SNpc to disinhibit dopamine release. This creates a complementary system where emotional signals can influence movement and learning.

The striatum is the largest and most complex nucleus of the basal ganglia, where up to $10,000$ influxes from the neocortex, amygdala, thalamus, and substantia nigra can converge on a single medium spiny projection neuron. This convergence allows for signal transformation through filtering, integration, and focus. Afferents include dopaminergic signals from the SNc (acting on D1 through D5 receptors) and glutamatergic signals from the thalamus (V-L and I-L nuclei). Locally, neurons use GABA, substance P (sP), and enkephalin (ENK), while various interneurons express calretinin (CR+), parvalbumin (PV+), or NADPH-d+ (somatostatin and neuropeptide Y) and acetylcholine (ACh).

The functional model of these connections is characterized by the ‘Go/Stop’ dynamic. The hyperdirect pathway from the cortex to the NST and then to the GPi/SNr provides rapid excitation (a ‘reset’). The direct pathway (Striatum to GPi/SNr) involves GABA, sP, and D1R, leading to focused inhibition that favors movement (the ‘Go’ signal). The indirect pathway (Striatum to GPe to NST to GPi/SNr) involves GABA, ENK, and D2R, resulting in thalamic inhibition that acts as a brake on competitive motor patterns (the ‘Stop’ signal). There is an estimated convergence ratio of $80:1$ from striatal projections to target neurons, ensuring network coherence. The striatum is also the primary site of dopamine deficiency in Parkinson's disease.

Roles in Motor Control and Behavior

The roles of the basal ganglia extend beyond simple movement execution. They are involved in the initiation or selection of actions based on internal or external signals, the facilitation of execution, sequential learning (chunking of motor sequences), and the motivational adjustment of motor output vigor. Research by Horak and Anderson ($1984-1985$) on primates showed that neuronal activity in the GPi is modified primarily during execution. Perturbing this activity changes movement kinematics rather than initiation. Inactivation of the GPi slows movement without affecting selection. Furthermore, optogenetic studies in mice show that movement initiation is preceded by an increase in SNc activity; inhibiting the SNc reduces the probability of movement initiation but does not modify a movement already in progress. In terms of non-motor behaviors, the basal ganglia contribute to emotions, mood, reinforcement learning, and decision-making through error encoding in reward prediction.

Advanced anatomical knowledge identifies disynaptic connections between the basal ganglia and the cerebellum. A study by Bostan and Strick (2018) using rabies virus retrograde transport revealed a pathway from the dentate nucleus (DN) of the cerebellum to the putamen. This integrates the cerebellum into the basal ganglia network. Additionally, the GPe has been identified as crucial for the reward system. It contains diverse cell types: Prototypic neurons ($70\%$; slow and fast PV+ projecting to the NST and GPi/SNr) and Archipallidal neurons ($30\%$; PV-, irregular activity, projecting back to the striatum as a ‘cancel pathway’ to suppress movement). Research by Farries et al. (2023) demonstrates that GPe subpopulations encode reward predictions and prediction errors (RPE) similarly to midbrain dopamine cells.

Pathophysiology of Parkinsonism and Bradykinesia

Basal ganglia dysfunctions manifest as perturbations of voluntary movement, the presence of involuntary movements, or both. Following the models of Albin, Young, Penney, and DeLong, akinetic syndromes (Parkinsonism) result from a hyperactive and rhythmic bursting GPi/SNr output, which over-inhibits the thalamus and NPP (‘too much brake’). Symptoms of Parkinsonism include resting tremor, rigidity, akinesia (poverty of movement), bradykinesia (slowness), and postural disturbances as described by Gowers (1886). The major biochemical anomaly is a marked depletion of striatal dopamine; manifestations appear when loss reaches approximately $70\%$, and loss exceeds $90\%$ at death.

The etiology of Parkinson's disease involves alpha-synuclein aggregation, mitochondrial dysfunction, oxidative stress, and lysosomal dysfunction. Recent hypotheses suggest an autoimmune component or a gut-brain axis trigger; specifically, intestinal infection with Gram-negative bacteria in Pink1-/- mice can elicit cytotoxic CD8+ T cells that decrease dopaminergic axonal density in the striatum. Neuronal vulnerability is also linked to extensive axonal arborization and defective autophagy. Bradykinesia is traditionally associated with dopaminergic deficiency and thalamo-cortical over-inhibition, resulting in elongated reaction times and reduced velocity/amplitude. Pathological beta oscillations ($13-30\,Hz$) in the NST are a hallmark of the parkinsonian state, correlating with symptom severity. These oscillations make information encoding less efficient. Dopamine replacement therapy (L-DOPA) increases pro-kinetic gamma oscillations ($300\,Hz$) and normalizes the triphasic response in the GPi/SNr.

Tremor, Rigidity, and Freezing of Gait

Parkinsonian rest tremor ($4-6\,Hz$) is a fluctuating condition that increases with cognitive load or stress. It is explained by the ‘dimmer-switch’ model where activity in the cortico-striatal circuit is synchronized by beta oscillations, influencing thalamic spike timing and facilitating resonance within the cerebello-thalamo-cortical circuit. Rigidity is a velocity-independent increase in muscle tone felt during passive mobilization. This is linked to hyperactive long-latency stretch reflexes (LLSR) due to high NST/GPi output and the loss of inhibitory control over the PPN in the brainstem.

Freezing of Gait (FOG) is an episodic, disabling disorder where patients feel their feet are ‘glued to the floor.’ It occurs more frequently as the disease progresses ($10\%$ at stage 1 to $>90\%$ at stage 4) and is triggered by turns, doorways, or stress. It may be partially reversed by visual or sensory feedback. The cause is likely a ‘cross-talk’ model where excessive cerebral integration overloads the basal ganglia. Deep Brain Stimulation (DBS) is a significant therapeutic advancement, using high-frequency electrical pulses delivered via micro-electrodes (usually in the NST) to reduce abnormal oscillations, although it has less benefit for gait, speech, and mood.

Hyperkinetic Disorders and Dopa-Induced Dyskinesia

Hyperkinetic syndromes result from a weak GPi/SNr output with abnormal phasic bursts (‘not enough brake’). Examples include dyskinesia, dystonia, chorea, hemiballismus, and tics. L-DOPA-induced dyskinesia (LID) is a common complication affecting most patients after $2-5$ years of treatment. It requires a pre-synaptic parkinsonism state (denervation) and pharmacological priming. Mechanistically, LID involves ultrasensitive dopamine signaling, increased endogenous dopamine turnover, and transcriptional overactivation of $\Delta FosB$ in the D1 direct pathway. Cholinergic interneurons in the striatum also become hyperexcitable. In LID, GPi discharge frequency decreases while GPe frequency increases. DBS of the GPi is often beneficial for managing these involuntary movements.

Dystonia is characterized by excessive involuntary muscle contractions causing abnormal postures. It can be primary (genetic) or secondary (medication, toxins, or stroke). Pathophysiological findings include a deficit of intracortical inhibition and an imbalance between the direct and indirect pathways. Specifically, PET scans show increased D1R availability and reduced D2R in the basal ganglia of humans with focal dystonia. In animal models, intra-putaminal infusion of muscarinic agonists (e.g., oxotremorine) induces a dystonic phenotype, suggesting that selective muscarinic antagonists could be a prospective treatment strategy. Overall, the basal ganglia comprise a complex dynamic system critical for movement preparation, automation, and reward-based learning, where striatal dysfunction is central to diverse motor disorders.